For its fourth fiscal quarter (ending December 31), Eli Lilly and Co (NYSE: LLY) has reported a 101% increase in E.P.S. from $2.43 a year ago to $4.88 in the current quarter. For the latest four quarters through December 31, E.P.S. were $11.71 compared to $5.82 a year ago — an increase of 101%.
Recent Price Action
Eli Lilly and Co (NYSE: LLY) stock closed at $870.37 on 2/6/25 after a large increase of 3.3%. Moreover, this advance was accompanied by exceptionally high trading volume at 200% of normal. The stock has risen 8.2% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Eli Lilly has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing highly consistent signals. Eli Lilly has a neutral Appreciation Score of 56 and a neutral Power Rating of 41, leading to the Low Neutral Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment